Abstract
Recently, there has been significant interest in using cannabidiol (CBD) in the pediatric population. Robust evidence exists for the anticonvulsant action of CBD in some childhood epileptic syndromes, and CBD can reduce anxiety symptoms, stereotyped behavior, hyperactivity, and sleep disorders. However, there are other diseases, such as fragile X syndrome and conditions resulting in intellectual disability, in which CBD use is developing. This article provides the reader with a discussion of the current scientific evidence regarding the use of CBD in the pediatric population. [ Psychiatr Ann . 2023;53(6):256–258.]
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call